May 2025
Dr. Mitra co-authored publication, Lithium exacerbates Lafora body formation in the Epm2a-/- Lafora disease mouse model".
February 2025
Silvia Vargas joined the lab.
Dr. Mitra Presents at Symposium
Dr. Mitra presented at the Lafora Disease Science Symposium in San Diego, California. She described studies to use glycogen synthase 1 as a target to treat neuronal glycogen storage diseases with a special emphasis on Lafora disease, Adult polyglucosan body disease, and PGBM1.
December 2024
Surbhi Gahlot, Ph.D., joined the lab as research scientist.
October 2024
James Osborn was the first lab member to join the Mitra lab at UT Southwestern.
September 2024
The Mitra lab received its first grant, an R01 to identify the mechanism for amylopectinosis (insoluble glycogen formation) in Polyglucosan body myopathy 1 (PGBM1) disease.